Accelerating 21st Century Cures

This is a golden age for biomedical research, with novel technologies and groundbreaking science revealing new pathways to diagnose, treat, prevent, or cure disease. Yet too many patients still lack lifesaving therapies. Last year, the US House Committee on Energy and Commerce launched the bipartisan 21st Century Cures initiative to consider opportunities to transform biopharmaceutical research and development. Now under review in Congress, the 21st Century Cures Act, proposes new ways to streamline clinical trials, incorporate patient perspectives into decision making, and speed the science of cures to the bedside. Are fundamental changes needed in how we invest in and oversee research, product development and review? Where along the arc of discovery, testing, approval, and marketing can we accelerate the pace of biomedical advances?

Festival: Spotlight Health 2015

Watch and Listen: Treatment

The Second City and Caring Across Generations have joined forces to develop a unique training program that strengthens... See more
Medical errors in hospitals rank as the third leading cause of death in the United States, exceeded only by cancer and... See more
Dip into a groundbreaking medical memoir by Kurt Newman, president and CEO of Children’s National Medical Center and... See more
Whether they remain free of diagnosable disease or become afflicted by dementia, our brains inevitably change as we... See more
Social capital “is the network and scaffolding, seen and unseen, that allows determined individuals to succeed,” writes... See more
Individual genetic makeup and the genetic signature of diseases vary tremendously, but the goal of matching them with... See more